Literature DB >> 8990203

Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau.

A D Alonso1, I Grundke-Iqbal, H S Barra, K Iqbal.   

Abstract

The microtubule-associated protein (MAP) tau is abnormally hyperphosphorylated in Alzheimer disease and accumulates in neurons undergoing neurofibrillary degeneration. In the present study, the associations of the Alzheimer-hyperphosphorylated tau (AD P-tau) with the high molecular weight MAPs (HMW-MAPs) MAP1 and MAP2 were investigated. The AD P-tau was found to aggregate with MAP1 and MAP2 in solution. The association of AD P-tau to the MAPs resulted in inhibition of MAP-promoted microtubule assembly. However, unlike the coaggregation of AD P-tau and normal tau, the association between AD P-tau and the HMW-MAPs did not result in the formation of filaments/tangles. The affinity of the tau-AD P-tau association was higher than that of HMW-MAPs-AD P-tau because normal tau inhibited the latter binding. The association between AD P-tau and the HMW-MAPs also appeared to occur in situ because these proteins cosedimented from the Alzheimer brain extracts, and, in the sediment, the levels of the HMW-MAPs correlated with the levels of AD P-tau. These studies suggested that the abnormally phosphorylated tau can sequester both normal tau and HMW-MAPs and disassemble microtubules but, under physiological conditions, can form tangles of filaments only from tau.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990203      PMCID: PMC19321          DOI: 10.1073/pnas.94.1.298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Assay of proteins in the presence of interfering materials.

Authors:  A Bensadoun; D Weinstein
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  Observations on the brains of demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1970-09       Impact factor: 3.181

4.  Ultrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle.

Authors:  H M Wisniewski; P A Merz; K Iqbal
Journal:  J Neuropathol Exp Neurol       Date:  1984-11       Impact factor: 3.685

5.  Decoration and stabilization of intact, smooth-walled microtubules with microtubule-associated proteins.

Authors:  R D Sloboda; J L Rosenbaum
Journal:  Biochemistry       Date:  1979-01-09       Impact factor: 3.162

6.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

Authors:  A C Alonso; I Grundke-Iqbal; K Iqbal
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

7.  Alzheimer paired helical filaments: immunochemical identification of polypeptides.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles.

Authors:  K S Kosik; L K Duffy; M M Dowling; C Abraham; A McCluskey; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain.

Authors:  C X Gong; S Shaikh; J Z Wang; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

10.  Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.

Authors:  J Z Wang; I Grundke-Iqbal; K Iqbal
Journal:  Brain Res Mol Brain Res       Date:  1996-06
View more
  134 in total

1.  Multiple forms of phosphatase from human brain: isolation and partial characterization of affi-gel blue binding phosphatases.

Authors:  L Y Cheng; J Z Wang; C X Gong; J J Pei; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

Review 2.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

3.  Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats.

Authors:  Gao-Shang Chai; Dong-Xiao Duan; Rong-Hong Ma; Jian-Ying Shen; Hong-Lian Li; Zhi-Wei Ma; Yu Luo; Lu Wang; Xin-Hua Qi; Qun Wang; Jian-Zhi Wang; Zelan Wei; Darrell D Mousseau; Li Wang; Gongping Liu
Journal:  Neurosci Bull       Date:  2014-11-12       Impact factor: 5.203

4.  Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.

Authors:  Y Jiang; A P Mizisin; A Rearden; C G Jolivalt
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

5.  Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases.

Authors:  Haruka Sudo; Peter W Baas
Journal:  Hum Mol Genet       Date:  2010-11-30       Impact factor: 6.150

6.  Role of glycosaminoglycans in determining the helicity of paired helical filaments.

Authors:  M Arrasate; M Pérez; J M Valpuesta; J Avila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 7.  Tau pathology generated by overexpression of tau.

Authors:  I Grundke-Iqbal; K Iqbal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 8.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

9.  β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

Authors:  Yulei Deng; Zhe Xiong; Paul Chen; Jing Wei; Shengdi Chen; Zhen Yan
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

10.  Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.

Authors:  Zhi Tang; Erika Bereczki; Haiyan Zhang; Shan Wang; Chunxia Li; Xinying Ji; Rui M Branca; Janne Lehtiö; Zhizhong Guan; Peter Filipcik; Shaohua Xu; Bengt Winblad; Jin-Jing Pei
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.